← Human Trials & Peer-Reviewed Studies
Effect of vitamin D supplementation on anthropometric indices among overweight and obese women: A double blind randomized controlled clinical trial.
Plain-language guide to PMID 29615318 (2018): double-blind randomized controlled trial of Vitamin D, K2, Magnesium and Zinc in 66 women.
Key Facts
- PMID
- 29615318
- Journal
- Diabetes & metabolic syndrome
- Year
- 2018
- Study type
- Randomized Controlled Trial
- Authors
- Roosta S et al. (6 authors)
- DOI
- 10.1016/j.dsx.2018.03.022
What This Study Did, in Plain Language
What Was Tested
Researchers studied Vitamin D, K2, Magnesium and Zinc in this randomized controlled trial publication.
The aim of this study was to investigate effect of vitamin D supplementation on anthropometric indices among women with overweight and obesity.
Before the intervention a 24-h dietary recall (3 days) were used to assess dietary intake of individuals.
Who Took Part
The study group was 66 women.
The age groups tagged for this paper are teenagers, young adults, adults, middle-aged adults and older adults, both men and women.
This double blind randomize clinical trial was conducted on 66 overweight and obese women.
How the Study Was Run
The researchers set it up as a randomized, double-blind and placebo-controlled study.
Random assignment meant chance, not the researchers, decided who got Vitamin D, K2, Magnesium and Zinc and who got the comparison, which limits bias.
Blinding on both sides kept the women and researchers unaware of who received Vitamin D, K2, Magnesium and Zinc.
Some women received a placebo instead of Vitamin D, K2, Magnesium and Zinc, giving a reference point.
Independent t test and multivariate repeated measure were used to data analysis.
What Was Measured
Topics PubMed links to this paper include Anthropometry, Body Mass Index, Case-Control Studies, Dietary Supplements, Obesity, Overweight and Prognosis.
The authors tagged it with the keywords Anthropometric indices, Vitamin D and Waist circumferences.
What This Means in Plain Language
The paper is a randomized, double-blind and placebo-controlled study of Vitamin D, K2, Magnesium and Zinc in 66 women.
Results are reported in around 3 sentences of the abstract; we leave them to the paper itself rather than summarise them.
The publication is from 2018 (Diabetes & metabolic syndrome), a journal based in Netherlands.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.